Therapeutic indications: Treatment of narcolepsy with cataplexy in adult and paediatric patients from the age of 7 years.
ADVERSE REACTIONS SHOULD BE REPORTED
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse reactions should also be reported to Neuraxpharm UK Ltd by:
- Email: pv-uk@neuraxpharm.com
- Phone number: +44 330 128 0919